Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation

Heart

Volumn 92, Issue 9, 2006, Pages 1244-1247

  Nergardh A ^a   Frick, M ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; FLECAINIDE; SOTALOL; VERAPAMIL; WARFARIN;

AGED; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCEPTION; PRIORITY JOURNAL; SINUS RHYTHM; SYMPTOMATOLOGY;

AGED; ATRIAL FIBRILLATION; CONFIDENCE INTERVALS; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; PERCEPTION; TIME FACTORS;

EID: 33748037368     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.082156     Document Type: Article

References (22)

1. Kannel WB, Abbott RD, Savage DD, et al. Epidemiological features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982;306:1018-22.
2. Kalman JM, Tonkin AM. Atrial fibrillation: epidemiology and the risk and prevention of stroke. Pacing Clin Electrophysiol 1992;15:1332-46.
3. Page R, Wilkinson W, Clair W, et al. Asymptomatic arrhythmias in patients witn symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994;89:224-7.
4. Savelieva I, Camm AJ. Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Intervent Cardiac Electrophysiol 2000;4:369-82.
5. Savelieva I, Paquette M, Dorian P, et al. Quality of life in patients with silent atrial fibrillation. Heart 2001;85:216-7.
6. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J 2001;22:1852-923.
7. Wyse DG, Waldo AL, DiMarco JP, et al. Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833.
8. Van Gelder IC, Hagens VE, Bosker HA, et al. Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-40.
9. Jenkins LS, Brodsky M, Schron E, et al. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149:112-20.
10. Hagens VE, Ranchor AV, Van Sonderen E, et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation: results from the Rate Control Versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol 2004;43:241-7.
11. Carlsson J, Miketic S, Windeler J, et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003;41:1690-6.
12. Altman DG. Some common problems in medical research. In: Altman DG, eds. Practical statistics tor medical research, 1st ed. London: Chapman and Hall, 1991:403-9.
13. Dorian P, Jung W, Newman D, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 2000;36:1303-9.
14. Grönefeld G, Lilienthal J, Kuck K, et al. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Eur Heart J 2003;24:1430-6.
15. Karlof I. Haemodynamic effect of atrial triggered versus fixed rate pacing at rest and during exercise in complete heart block. Acta Med Scand 1975;197:195-206.
16. Daoud EG, Weiss R, Bahu M, et al. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 1996;78:1433-6.
17. Grogan M, Smith HC, Gersh BJ, et al. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69:1570-3.
18. Frykman V, Frick M, Jensen-Urstad M, et al. Asymptomatic versus symptomatic persistent atrial fibrillation: clinical and noninvasive characteristics. J Intern Med 2001;250:390-7.
19. Hindricks G, Piorkowski C, Tanner H, et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation. Circulation 2005;112:307-13.
20. Nishino M, Hoshida S, Tanouchi J, et al. Time to recover from atrial hormonal, mechanical and electrical dysfunction after successful electrical cardioversion of persistent atrial fibrillation. Am J Cardiol 2000;85:1451-4.
21. Wozakowska-Kaplon B, Opolski G. Concomitant recovery of atrial mechanical and endocrine function after cardioversion in patients with persistent atrial fibrillation. J Am Coll Cardiol 2003;41:1716-20.
22. Wozakowska-Kaplon B, Opolski G. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study. Int J Cardiol 2004;96:171-6.